Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
8.18
-1.12 (-12.04%)
Jun 23, 2025, 1:31 PM - Market open
ZYBT Employees
Zhengye Biotechnology Holding had 286 employees as of December 31, 2023. The number of employees decreased by 8 or -2.72% compared to the previous year.
Employees
286
Change (1Y)
-8
Growth (1Y)
-2.72%
Revenue / Employee
$91,298
Profits / Employee
$9,761
Market Cap
387.66M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 286 | -8 | -2.72% |
| Dec 31, 2022 | 294 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
ZYBT News
- 4 weeks ago - Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F - GlobeNewsWire
- 5 months ago - Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option - GlobeNewsWire
- 5 months ago - U.S. IPO Weekly Recap: Flowco Launches First Major IPO Of 2025 As Smithfield, Others Join The Pipeline - Seeking Alpha
- 5 months ago - Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering - GlobeNewsWire
- 5 months ago - Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering - GlobeNewsWire
- 1 year ago - Zhengye Biotechnology's Growth Slows As It Seeks U.S. IPO - Seeking Alpha
- 1 year ago - Chinese animal health company Zhengye Biotechnology Holding files for a $20 million US IPO - Renaissance Capital
- 1 year ago - Zhengye Biotechnology IPO Registration Document (F-1) - SEC